Skip to content

Determination of Apium graveolens L. fruits effect on diabetic patients

Determination of Apium graveolens L. fruits effect on HbA1C, 2HPP & FBS in type 2 diabetic patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014081718828N1
Enrollment
74
Registered
2017-03-05
Start date
2017-02-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabete. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: The participants in control group receive three cellulose capsules per day, 30 min before every meal, for three months along with standard treatments. Intervention 2: The participants
Treatment - Drugs
The participants in control group receive three cellulose capsules per day, 30 min before every meal, for three months along with standard treatments.
The participants in intervention group receive three celery fruit capsules per day, 30 min before every meal, for three months along with standard treatments.

Sponsors

Yazd University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with diabetes type 2; Patients within the age range 20-80; Patients with the ability to speak Persian; Patients satisfaction with entering the study Exclusion criteria: Taking insulin; Taking common non-medical products; Patients who cannot take celery fruit capsules for any given reason; Patients with diabetes type 1; Pregnant and breastfeeding women; Patients taking Aspirin, Warfarin, Clopidogrel; Patients receiving diuretics or thyroid treatment

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hemoglobin A1c (HbA1c). Timepoint: 3 months after drug use. Method of measurement: Blood test.

Secondary

MeasureTime frame
Fasting blood sugar (FBS). Timepoint: 3 months after drug use. Method of measurement: Blood Test.;2 hour Post Prandial (2hpp). Timepoint: 3 months after drug use. Method of measurement: Blood Test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlimohamad Ranjbar Jamal abadi

Yazd University of Medical Sciences

amranjbar@razi.tums.ac.ir+98 132537089

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026